CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN

被引：70

作者：

CORDEN, BJ

FINE, RL

OZOLS, RF

COLLINS, JM

机构：

[1] NCI,DIV CANC TREATMENT,CLIN PHARMACOL BRANCH,BLDG 10,ROOM 6N119,BETHESDA,MD 20205

[2] NCI,DIV CANC TREATMENT,MED BRANCH,BETHESDA,MD 20205

来源：

关键词：

D O I：

10.1007/BF00552723

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：38 / 41

页数：4

共 15 条

[1] BELT RJ, 1979, CANCER TREAT REP, V63, P1515
[2] CHARY KK, 1977, CANCER TREAT REP, V61, P367
[3] CIS-DIAMMINEDICHLOROPLATINUM, VINBLASTINE, AND BLEOMYCIN COMBINATION CHEMOTHERAPY IN DISSEMINATED TESTICULAR CANCER
EINHORN, LH
DONOHUE, J
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (03) : 293 - 298
[4] GORMLEY PE, 1979, CLIN PHARMACOL THER, V25, P351
[5] STABILITY OF CISPLATIN IN AQUEOUS-SOLUTION
GREENE, RF
CHATTERJI, DC
HIRANAKA, PK
GALLELLI, JF
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (01): : 38 - 43
[6] CLINICAL KINETICS OF INTACT CISPLATIN AND SOME RELATED SPECIES
HIMMELSTEIN, KJ
PATTON, TF
BELT, RJ
TAYLOR, S
REPTA, AJ
STERNSON, LA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) : 658 - 664
[7] CIRCADIAN TIME-DEPENDENCE OF CISPLATIN URINARY KINETICS
HRUSHESKY, WJM
BORCH, R
LEVI, F
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) : 330 - 339
[8] JACOBS C, 1980, CANCER TREAT REP, V64, P1223
[9] ANALYSIS OF PLATINUM IN BIOLOGICAL-MATERIALS BY FLAMELESS ATOMIC-ABSORPTION SPECTROPHOTOMETRY
LEROY, AF
WEHLING, ML
SPONSELLER, HL
FRIAUF, WS
SOLOMON, RE
DEDRICK, RL
LITTERST, CL
GRAM, TE
GUARINO, AM
BECKER, DA
[J]. BIOCHEMICAL MEDICINE, 1977, 18 (02): : 184 - 191
[10] PLATINUM NEPHROTOXICITY
MADIAS, NE
HARRINGTON, JT
[J]. AMERICAN JOURNAL OF MEDICINE, 1978, 65 (02) : 307 - 314